Pyrogen Testing Market - Current State and Future Prospects

The Global Pyrogen Testing Market is expected to clock US$ 2.9 billion by 2031 owing to growing focus on personalized medicine, increasing R&D in the pharmaceutical & biotechnology industry, launch of various drugs, favorable regulatory policies and rising incidence of infectious diseases.

Clairvoyance Research conducted an in-depth market analysis study of the global pyrogen testing market. The study comprehensively analyzes the market from different perspectives and provides granular insights on hot revenue pockets, headwinds & tailwinds impacting the market, quantitative (market size & forecasts) and qualitative analysis on different segments, key strategies and competitive landscape.

Access ‘Sample Pages’ of the Report

Key Market Trends

In order to be competitive in the market several prominent players are progressively implementing several strategies such as technological advancements, acquisitions and/or collaborative initiatives with several organizations, research centers & companies for R&D activities. For instance - In Oct 2020, Lonza launched its PyroCell MAT System, a highly sensitive and sustainable Monocyte Activation Test (MAT) suitable for detecting a broad range of pyrogens without the need for experimental animals. In Jun 2020, Lonza Sales AG, joined forces with Sanquin Reagents B.V. to enable drug developers and quality control laboratories to take full advantage of the power of the Monocyte Activation Test (MAT). In April 2019, Lonza launched world’s first fully automated and integrated plate-based PyroTec PRO Robotic Solution for endotoxin testing. Endotoxin testing was simplified by combining the robotic liquid platform with Lonza’s WinKQCL Software.

The global pyrogen testing market has been analyzed from four different perspectives – Products & Services, Test Type, End User and Region.

Key Takeaways – Products & Services Perspective

Based on products & services, the market has been segmented into instruments, kits & reagents and services. The kits & reagents segment accounted for the largest share in the market owing to its easy accessibility and its frequent purchase for each test performed as compared to the one-time purchase of instruments.

Key Takeaways – Test Type Perspective

Based on test type, the pyrogen testing market has been segmented into rabbit pyrogen test (RPT), monocyte activation test (MAT), limulus amoebocyte lysate (LAL) test and others. The limulus amoebocyte lysate (LAL) test segment holds the largest share in the market. LAL test is widely used test in pharmaceuticals for the screening of bacterial endotoxins owing to its benefits over other tests.

Key Takeaways – Regional Perspective

Based on region, the global pyrogen testing market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America dominated the pyrogen testing market, followed by Asia Pacific. The large share of North America in the global market can largely be attributed to the developed healthcare infrastructure, presence of key prominent players, stringent regulations, presence of major pharmaceutical & biotechnology companies and rising number of drug approvals.

Snapshot - Competitive Landscape

The pyrogen testing market is marked by presence of prominent players such as Merck KGaA, Thermo Fisher Scientific Inc., Charles River Laboratories, Lonza, GenScript, WuXi AppTec, ASSOCIATES OF CAPE COD, INC., Ellab, BIOMÉRIEUX SA, Sanquin. Other players operating in the market are FUJIFILM Wako Pure Chemical Corporation, Eurofins Scientific, Hycult Biotech, InvivoGen, among others.

For deep-rooted insights, please explore the Report

NEED MORE?

• Talk to us about your requirements and get a customized report
• Get more details about the content of report
• Request a Free ‘Sample Pages’ of the report